Plasma membrane-localized TMEM16 proteins are indispensable for expression of CFTR.


Journal

Journal of molecular medicine (Berlin, Germany)
ISSN: 1432-1440
Titre abrégé: J Mol Med (Berl)
Pays: Germany
ID NLM: 9504370

Informations de publication

Date de publication:
05 2019
Historique:
received: 18 10 2018
accepted: 05 03 2019
revised: 22 02 2019
pubmed: 28 3 2019
medline: 23 6 2020
entrez: 28 3 2019
Statut: ppublish

Résumé

The cystic fibrosis transmembrane conductance regulator (CFTR) is the secretory chloride channel in epithelial tissues that has a central role in cystic fibrosis (CF) lung and gastrointestinal disease. A recent publication demonstrates a close association between CFTR and TMEM16A, the calcium-activated chloride channel. Thus, no CFTR chloride currents could be detected in airways and large intestine from mice lacking epithelial expression of TMEM16A. Here, we demonstrate that another plasma membrane-localized TMEM16 paralogue, TMEM16F, can compensate for the lack of TMEM16A. Using TMEM16 knockout mice, human lymphocytes, and a number of human cell lines with endogenous protein expression or heterologous expression, we demonstrate that CFTR can only function in the presence of either TMEM16A or TMEM16F. Double knockout of intestinal epithelial TMEM16A/F expression did not produce offsprings, suggesting a lethal phenotype in utero. Plasma membrane-localized TMEM16A or TMEM16F is required for exocytosis and expression of CFTR in the plasma membrane. TMEM16A/F proteins may therefore have an impact on disease severity in CF. KEY MESSAGES: • Cystic fibrosis is caused by the defective Cl

Identifiants

pubmed: 30915480
doi: 10.1007/s00109-019-01770-4
pii: 10.1007/s00109-019-01770-4
doi:

Substances chimiques

ANO6 protein, mouse 0
ANO6 protein, human 0
Anoctamin-1 0
Anoctamins 0
Phospholipid Transfer Proteins 0
Cystic Fibrosis Transmembrane Conductance Regulator 126880-72-6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

711-722

Références

Biochemistry. 1983 Dec 20;22(26):6134-40
pubmed: 10627119
Pflugers Arch. 2001;443 Suppl 1:S3-7
pubmed: 11845294
Am J Respir Cell Mol Biol. 2004 Mar;30(3):411-9
pubmed: 12972400
Nature. 1992 Oct 29;359(6398):832-5
pubmed: 1331807
Cell. 2005 Nov 4;123(3):375-82
pubmed: 16269330
Trends Pharmacol Sci. 2007 Jul;28(7):334-41
pubmed: 17573123
Mol Pharmacol. 2008 Mar;73(3):758-68
pubmed: 18083779
Science. 2008 Jan 11;319(5860):210-3
pubmed: 18187657
Dev Dyn. 2008 Sep;237(9):2566-74
pubmed: 18729231
Cell Calcium. 2009 Oct;46(4):233-41
pubmed: 19783045
J Biol Chem. 2010 Mar 5;285(10):7838-45
pubmed: 20056604
Nature. 2010 Dec 9;468(7325):834-8
pubmed: 21107324
Pflugers Arch. 2011 Aug;462(2):195-208
pubmed: 21607626
Cell Physiol Biochem. 2011;28(4):715-24
pubmed: 22178883
J Neurosci. 2013 Feb 20;33(8):3545-56
pubmed: 23426682
Cell Death Dis. 2013 Apr 25;4:e611
pubmed: 23618909
Sci Signal. 2013 Aug 27;6(290):ra73
pubmed: 23982204
Front Endocrinol (Lausanne). 2013 Sep 17;4:125
pubmed: 24062727
Physiol Rev. 2014 Apr;94(2):419-59
pubmed: 24692353
Pflugers Arch. 2015 Jun;467(6):1203-13
pubmed: 24974903
Chem Senses. 2015 Feb;40(2):73-87
pubmed: 25500808
J Biol Chem. 2015 Mar 6;290(10):6270-80
pubmed: 25589784
Nat Commun. 2015 Feb 05;6:6245
pubmed: 25651887
Sci Rep. 2015 Mar 12;5:9038
pubmed: 25762484
FASEB J. 2016 Feb;30(2):727-37
pubmed: 26481309
Pflugers Arch. 2016 May;468(5):805-16
pubmed: 26873248
Cell Mol Life Sci. 2017 Jan;74(1):173-181
pubmed: 27535660
FASEB J. 2017 May;31(5):2123-2134
pubmed: 28183802
J Allergy Clin Immunol. 2018 Apr;141(4):1259-1268.e11
pubmed: 28754608
Sci Rep. 2017 Sep 29;7(1):12397
pubmed: 28963502
Proc Natl Acad Sci U S A. 2017 Dec 26;114(52):E11161-E11169
pubmed: 29229864
Cell Signal. 2018 Apr;44:10-19
pubmed: 29331508
Int J Mol Sci. 2018 Jun 18;19(6):null
pubmed: 29912162
FASEB J. 2019 Mar;33(3):4502-4512
pubmed: 30586313
Sci Rep. 2019 Jan 24;9(1):619
pubmed: 30679690
Front Pharmacol. 2019 Jan 29;10:3
pubmed: 30761000
Curr Opin Neurobiol. 1996 Jun;6(3):365-71
pubmed: 8794083

Auteurs

Roberta Benedetto (R)

Physiological Institute, University of Regensburg, University Street 31, D-93053, Regensburg, Germany.

Jiraporn Ousingsawat (J)

Physiological Institute, University of Regensburg, University Street 31, D-93053, Regensburg, Germany.

Inês Cabrita (I)

Physiological Institute, University of Regensburg, University Street 31, D-93053, Regensburg, Germany.

Madalena Pinto (M)

Physiological Institute, University of Regensburg, University Street 31, D-93053, Regensburg, Germany.

Joana R Lérias (JR)

Physiological Institute, University of Regensburg, University Street 31, D-93053, Regensburg, Germany.

Podchanart Wanitchakool (P)

Physiological Institute, University of Regensburg, University Street 31, D-93053, Regensburg, Germany.

Rainer Schreiber (R)

Physiological Institute, University of Regensburg, University Street 31, D-93053, Regensburg, Germany.

Karl Kunzelmann (K)

Physiological Institute, University of Regensburg, University Street 31, D-93053, Regensburg, Germany. karl.kunzelmann@ur.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH